CDMO Market to Reach USD 465.24 Billion by 2032, Driven by Demand for Scalable Solutions
The global CDMO market is projected to hit USD 465.24 billion by 2032, fueled by growing demand for scalable manufacturing, advanced clinical research services, and cost-effective drug development. Increasing outsourcing trends across pharmaceutical and biotech sectors position CDMOs as key partners in accelerating innovation and market delivery.